“Antitumor Activity of Dehydroxymethylepoxyquinomicin (DHMEQ) in Monotherapy and Combination with Cisplatin in the SKOV-3 Ovarian Cancer Model”, J. Can. Res. Updates, vol. 13, pp. 12–18, Sep. 2024, doi: 10.30683/1929-2279.2024.13.03.